Document Detail


Immunological aspects of epilepsy.
MedLine Citation:
PMID:  20885000     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In recent years, the concept of an immunological background of some types of epilepsy has been gaining an increasing number of supporters. The following article is an attempt to review the most significant studies that explore irregularities in patients with intractable epilepsy, search for and identify the immunological causal factors of seizures and, finally, associate these factors with particular syndromes that manifest in refractory epilepsy. We also discuss the efficacy of immunomodulatory treatment in the recognized syndromes. Last, we focus on the immunological abnormalities found in patients undergoing antiepileptic therapy with classical antiepileptic drugs as well as changes in the immune system that could be provoked by an epileptic seizure itself.
Authors:
Radosław Zarczuk; Dariusz Łukasik; Marian Jedrych; Kinga K Borowicz
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pharmacological reports : PR     Volume:  62     ISSN:  1734-1140     ISO Abbreviation:  Pharmacol Rep     Publication Date:    2010 Jul-Aug
Date Detail:
Created Date:  2010-10-04     Completed Date:  2011-01-12     Revised Date:  2011-11-28    
Medline Journal Info:
Nlm Unique ID:  101234999     Medline TA:  Pharmacol Rep     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  592-607     Citation Subset:  IM    
Affiliation:
Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Jaczewskiego 8, PL 20-090 Lublin, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anticonvulsants / therapeutic use*
Drug Resistance
Encephalitis / complications,  immunology
Epilepsy / drug therapy,  etiology,  immunology*
Humans
Immunologic Factors / therapeutic use*
Lupus Erythematosus, Systemic / complications,  immunology
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Immunologic Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of oxycodone and oxycodone/naloxone in cancer pain management.
Next Document:  Neonatal DSP-4 treatment impairs 5-HT(1B) receptor reactivity in adult rats. Behavioral and biochemi...